| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
The Endocrine Society's mission is to advance excellence in endocrinology and be an integrative force in scientific research and medical practice. Such progress depends on integrity in the conduct of scientific research and truthful representation of findings. Specific guidelines regarding the Society's expectations for ethical conduct can be found in the Code of Ethics of The Endocrine Society and the Ethical Guidelines for Publications of Research.
The journal editors and publication oversight committees of The Endocrine Society are dedicated to upholding high ethical standards in its publications and expect authors and reviewers to do the same.
Endocrine Reviews publishes bimonthly scholarly review articles in all areas of experimental and clinical endocrinology. The Journal considers articles addressing traditional hormones, locally acting regulatory molecules, and other molecules that act in ways that are hormone-like, e.g., cytokines or growth factors. The Journal strives to publish a mixture of basic, transitional, and clinically relevant articles of general interest.
Each manuscript should present a timely, authoritative review of its focal topic. Authors should provide sufficient background information to allow both endocrinologists and other scientists to gain both knowledge and perspective of the subject. We emphasize publication of articles that present a critical review of previous findings, as opposed to a simple compilation of previously published data and interpretations. While a limited amount of new data may be included to buttress the author's point of view, manuscripts that deal primarily with new findings should be submitted to Endocrinology or The Journal of Clinical Endocrinology & Metabolism (JCEM) or Molecular Endocrinology.
Note that all articles submitted to Endocrine Reviews, whether solicited or not, will undergo peer review. Manuscripts will be reviewed for scientific accuracy, clarity, and balance of perspective by members of the Editorial Board and other experts in the field. Manuscripts that focus entirely on the author's previous contributions to the literature will not be accepted. The bibliography should be comprehensive for current or recent citations but need not include all previous references. To this end, appropriate recent reviews should be cited whenever possible. However, we consider historical perspective very important; use of reviews should not preempt citation of early seminal publications.
Manuscripts may be solicited by the Editor-in-Chief, or proposals for manuscripts may be submitted independently by interested individuals. When submitting a proposal, authors must include the following items:
1. A full outline of the proposed review, listing all topics to be covered
2. A brief (1 page) narrative of the material to be covered in the manuscript, including a statement on why the topic is important and timely
3. A curriculum vitae for each author, including a full bibliography of published work
4. A completion date for the manuscript.
These items should be e-mailed to endoreviews{at}endo-society.org. Do not upload them to Rapid Review.
Once a proposal has been reviewed by the editors, the author will be notified of its status.
Please submit your manuscript to Endocrine Reviews through the Rapid Review system at the following site: https://www. rapidreview.com/tes/CALogon.jsp. If this is your first submission through E-Review, click on "New to Rapid Review?" to create an author account. If you already have an account from a previous submission, enter your username and password to submit a new or revised manuscript. If you have forgotten your username and/or password, e-mail the editorial office (endoreviews{at}endo-society.org) for assistance. Note that your author account is the same for JCEM, Endocrinology, Molecular Endocrinology, and Endocrine Reviews. Authors should be aware that in submitting a manuscript for consideration by Endocrine Reviews, they are submitting their paper to The Endocrine Society Central Journals Office database, which is accessible by the Editors-in-Chief of all the Society's journals.
All submissions must include:
If you need any assistance with the submission of your paper, please contact the Editorial Office at 301-951-2603, or endoreviews{at}endo-society.org.
The Journal requires that all submissions be submitted in a two-column format that follows these guidelines:
The title page should include the following:
Please use the following guidelines when preparing the abstract:
An outline of the manuscript's contents helps to lead the reader by providing preliminary information on the structure of the review.
The article should begin with a brief introductory statement that places the work to follow in historical perspective and explains its intent and significance.
The organization of this privileged section of the review is left to the authors. However, the organization should be logical and readily comprehended by the reader. As indicated above, an outline that indicates this organization is desirable.
The acknowledgment section should include the names of those people who contributed to a study but did not meet the requirements for authorship. The corresponding author is responsible for informing each person listed in the Acknowledgments section that they have been included and providing them with a description of their contribution so that they know the activity for which they are considered responsible.
References to the literature should be cited in numerical order (in parentheses) in the text and listed in the same numerical order at the end of the manuscript on a separate sheet or sheets. There must be only one reference to a number.
The number of references cited should be kept to a reasonable minimum; to this end, appropriate recent reviews should be cited whenever possible.
Examples of the reference style that should be used are given below. The titles of journals should be abbreviated according to the style used in the Index Medicus.
Journal articles and abstracts: List all authors. The citation of unpublished observations, of personal communications, and of manuscripts in preparation or submitted for publication is not permitted in the bibliography. Such citations should be inserted at appropriate places in the text, in parentheses and without serial number, or be presented in the footnotes. The citation of manuscripts in press (i.e., accepted for publication) is permitted in the bibliography; the name of the journal in which they appear must be supplied. If references to personal communications are made, authors are encouraged to keep written proof of the exchange. If it is necessary to cite an abstract because it contains substantive data not published elsewhere, it must be designated at the end of the reference [e.g., 68:313 (Abstract)]. The author is responsible for the accuracy of references.
Books: List all authors or editors.
Sample References
Tables must be constructed as simply as possible and be intelligible without reference to the text. Each table must have a concise heading. A description of experimental conditions may appear together with footnotes at the foot of the table. Tables must not simply duplicate the text or figures. The width of the table must be designed to occupy one or two journal columns, with no more than four (4) table columns or eight (8) to 10 table columns, respectively.
Please review the detailed instructions for preparing digital art at http://art.cadmus.com/da/index.jsp. E-mail queries can be sent to digitalart{at}cadmus.com. All figures must display the figure number.
Sizing the figure: The author is responsible for providing digital art that has been properly sized, cropped, and has adequate space between images. Plan the size of the figure to fill 1, 1.5, or 2 columns in the printed journal (see chart below for dimensions). In most cases, figures should be prepared for 1-column width. Produce original art at the size it should appear in the printed journal. (Note for PowerPoint users: The sizing instructions do not apply if you are submitting PowerPoint files for print production in E-Review. On the submission page, check boxes to indicate that the figures are the correct size and resolution.)
1 column = 18 picas, 7.5 cm, 3.0 in
1.5. columns = 30 picas, 12.5 cm, 5.0 in
2 columns = 38 picas, 16.0 cm, 6.5 in
Lettering: At 100% size, no lettering should be smaller than 8 point (0.3 cm high) or larger than 12 point (0.4 cm high). Use bold and solid lettering. Lines should be thick, solid, and no less than 1-point rule. Avoid the use of reverse type (white lettering on a darker background). Avoid lettering on top of shaded or textured areas. Titles should be clear and informative. Keep wording on figures to a minimum, and confine any explanation of figures to their separate-page legends. Label only one vertical and one horizontal side of a figure. Freehand lettering or drawing is unacceptable.
Special requirements for 4-color art: Save files in CMYK mode (cyan-magenta-yellow-black). Color saturation of the shadow portion cannot exceed 280% (%cyan + %magenta + %yellow + %black cannot exceed 280%).
Shading: Avoid the use of shading, but if unavoidable, use a coarse rather than a fine screen setting (80-100 line screen is preferred). Avoid 1-20% and 70-99% shading; make differing shades vary by at least 20%, i.e., 25%, 45%, 65%. Instead of shading, denote variations in graphs or drawings by cross-hatching; solid black; or vertical, horizontal, or diagonal striping. Avoid the use of dots.
Grouped figures: For grouped figures, indicate the layout in a diagram. Place grouped figures so that they can be printed in 1 column width with uniform margins. Indicate magnification in the legends and by internal reference markers in the photographs. Their length should represent the fraction or multiple of a micrometer, appropriate to the magnification.
Graphs: Graphs with axis measures containing very large or small numbers should convert to easily readable notations. Example: For an ordinate range of "counts per minute" values from 1,000 to 20,000, the true value may be multiplied by 10-3 (scale would read from 1 to 20) and the ordinate axis display "cpm (×10-3)." Similarly, for a Scatchard plot with values ranging from 0.1 to 2 femtomolar (10-15 m), the scale may run from 0.1 to 2 with the abscissa labeled "m(×10-15)." Three-dimensional bar graphs will not be published if the information they refer to is only two-dimensional.
Supplemental Data allows authors to enhance papers in Endocrine Reviews by making additional substantive material available to readers. Supplemental Data may take the form of figures, tables, datasets, derivations, or videos and is published only in Endocrine Reviews online; it does not appear in the printed version of the journal. Authors who wish to include Supplemental Data should state so in the cover letter when the manuscript is submitted.
Supplemental Data files should be submitted through Rapid Review at the time of manuscript submission and will be reviewed along with the manuscript. The files should be uploaded in the field marked "Upload Supplemental Data Files", and should NOT be attached with the manuscript and figure files. Authors should refer to the Supplemental Data in the manuscript at an appropriate point in the text or figure/table legend.
The file formats listed below may be used for Supplemental Data. Provide a brief description of each item in a separate HTML or Word file (i.e., figure or table legends, captions for movie or sound clips, etc.). Do not save figure numbers, legends, or author names as part of an image. File sizes should not exceed 5 MB. Images should not exceed 500 pixels in width or height. Do not use tabs or spaces for Word or WordPefect tables; please use the table functions available within these word processing programs to prepare tables. For web pages, provide a complete list of files and instructions for creating directories.
.htm, HTML*
.jpg, JPEG image*
.gif, Graphical image
.pdf, Adobe Portable Document Format
.xls, MS Excel Spreadsheet
.mov, Quick Time
.wav, Sound
.doc, MS Word 6 documents**
.txt, Plain ASCII*
*These files can be viewed directly on standard web browsers.
**MS Word may be used for text only.
All nonstandard abbreviations in the text must be defined immediately after the first use of the abbreviation. The list of Standard Abbreviations is given in the link.
Failure to notify the editor that some results in the manuscript are being or have been previously published will result in placement of a notice in the journal that the authors have violated the Ethical Guidelines for Publication of Research in The Endocrine Society Journals. The journal publishes original research and review material. Material previously published in whole or in part shall not be considered for publication. This includes materials published in any form of mass communication. At the time of submission, authors must divulge in their cover letter all prior publications or postings of the material in any form of media. Abstracts or posters displayed for colleagues at scientific meetings need not be reported. Other postings of any part of the submitted material on web pages, as well as those essential for participation in required registries will be evaluated by the Editor-In-Chief, who shall determine if those postings are material enough to constitute prior publication.
An author should have participated in either the conception or planning of the work, the interpretation of the results and the writing of the paper. An acknowledgment accompanying the paper is appropriate recognition for others who have contributed to a lesser extent, e.g., provision of clones, antisera or cell lines, or reading and reviewing manuscripts in draft. The signature of each author on the Affirmation of Originality and Copyright Release form that must be submitted with the manuscript indicates that all authors have had a part in the writing and final editing of the report, all have been given a copy of the manuscript, all have approved the final version of the manuscript, and all are prepared to take public responsibility for the work, sharing responsibility and accountability for the results.
The critical and confidential review of manuscripts is an essential element of research publications. Every scientist has an obligation to contribute to the peer review process by serving as a reviewer. Among the obligations of reviewers is the commitment to providing an expert, critical, and constructive scientific and literary appraisal of research reports in their fields of knowledge, skills, and experience in a fair and unbiased manner. In order to facilitate the prompt sharing of scientific results, it is also the obligation of each reviewer to complete their assignments promptly, within the editor's deadline. Should a delay in their review occur, the reviewer has the obligation to notify the editor at once.
Reviewers should not review a manuscript if: 1) they do not think that they are competent to assess the research described, 2) they believe there is a conflict of interest or personal or professional relationship with the author(s) that might bias their assessment of the manuscript, or (3) there is any other situation that could bias their review. Employment at the same institution as one of the authors does not automatically represent a conflict. Having previously reviewed the article for another journal does not disqualify a reviewer, although the editor should be informed so the reviewer's perspective can be considered. In circumstances when reviewers need to recuse themselves, they should notify the editor promptly, preferably with an explanation. If reviewers are uncertain whether they should recuse themselves, they should consult with the editor.
The reviewer should strive to provide accurate, detailed, and constructive criticisms, and the review should be supported by appropriate references, especially if unfavorable. The reviewer should also note whether the work of others is properly cited. If the reviewer notes any substantial resemblance of the manuscript being reviewed to a published paper or to a manuscript submitted at the same time to another journal, they should promptly report this to the editor.
No part of the manuscript under review should ordinarily be revealed to another individual without the permission of the editor. If a reviewer consults a colleague on a particular point, this fact, and the name of the collaborator or consultant, should be reported to the editor, preferably in advance. With these exceptions, a reviewer must obtain through the editor written permission from the authors to use or disclose any of the unpublished content of a manuscript under review.
When preparing digital images, authors must adhere to the following guidelines as stated in The CSE's White Paper on Promoting Integrity in Scinetific Journal Publications:
Proofs and a reprint order form are sent to the corresponding author unless the Editorial Office is advised otherwise. The author should designate by footnote on the title page of the manuscript the name and address of the person to whom reprint requests should be directed. Questions about reprints should be referred to Cadmus Professional Communications at 410-819-3912 (direct) or 800-407-9190 (toll-free).
There is no submission fee for The Endocrine Society journals. There will be a charge of $225 per color figure for members of The Endocrine Society in they are the first or last author on the paper, and $700 per color figure for non-members. Authors must submit usable digital art that passes Cadmus's Rapid Inspector. Queries on page charges may be directed to Joy Carter at Cadmus Professional Communications (410-691-6439; fax 410-684-2792).
Accepted manuscripts will be posted online, as submitted, within a week of acceptance without copyediting, reformatting, or corrections. These manuscripts are citable by a unique DOI (Digital Object Identifier), which will also appear in the final printed article. Authors will still make corrections for the copyedited manuscript that will appear in print and in the final online version. When the final version of the article is published in print, it will also be published online and will replace the REP version. The REP version will be archived and will remain available for reference.
The editorial office will retain all manuscripts and related documentation (correspondence, reviews, etc.) for 12 months following the date of publication or rejection.
The Endocrine Society has signed an agreement with the National Institutes of Health (NIH) that creates a new option to comply with the NIH policy on enhanced access. This program will remove the current burden for authors to submit their manuscripts to PubMed Central. As a result of TES' participation in this program, all authors who published NIH-funded articles have no obligation to submit manuscripts to the NIH archive because TES will do this on their behalf. For more information, see http://www.endo-society.org/journals/AuthorInfo/tes_nih_policy.cfm.
Authors may archive their Rapid Electronic Publication (REP) authors' unedited manuscript PDF in their institutional archive as well as PMC, UKPMC, and other PMCI repositories immediately upon print publication - no delay is required. Authors may not use the PDF of the final, typeset version for this purpose.
To ensure that your article is cited properly, it is important that you download the PDF of the manuscript from the journal's online web site because the title page of the PDF is stamped with the necessary citation information. Otherwise, users will not be able to provide the information needed for citation tracking.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |